J Cerebrovasc Endovasc Neurosurg.  2018 Mar;20(1):53-60. 10.7461/jcen.2018.20.1.53.

The Evolution of the Neurosurgical Treatment of Ischemic Stroke

Affiliations
  • 1Department of Neurosurgery, Medical College of Georgia, Augusta University, Augusta, GA, USA. jwithrow@augusta.edu

Abstract

The neurosurgical approach to the management of ischemic stroke has evolved dramatically over the past century with the bulk of these changes occurring over the past 25 years. With recent advances in technology and continued refinements in neurosurgical techniques there has been significant improvement to the safety and efficacy of our treatment options. The focus of this article will be to review the historical and recent reports in the literature related to revascularization techniques.

Keyword

Brain ischemia/drug therapy; Fibrinolytic agents; Stroke/diagnosis; Thrombolytic therapy; Tissue plasminogen activator/therapeutic use; Infusions; intra-arterial; Stents

MeSH Terms

Fibrinolytic Agents
Stents
Stroke*
Thrombolytic Therapy
Fibrinolytic Agents

Figure

  • Fig. 1 (A) shows the initial deployment of the Penumbra device proximal to the clot. (B, C) show the separator disrupting the clot and suctioning of the fragments through the microcatheter.

  • Fig. 2 (A, B) show the deployment of a stent retriever. The device and microcatheter are inserted distal to the clot and the microcatheter is withdrawn proximally leaving the stent retriever embedded throughout the clot. (C) shows the stent retriever being withdrawn into the microcatheter carrying the clot after the 3-5 minute waiting period for the clot retriever to stabilize within the clot.


Reference

1. Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015; 01. 372(1):11–20.
2. Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013; 03. 368(10):893–903.
Article
3. Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015; 03. 372(11):1009–1018.
Article
4. Chao WH, Kwan ST, Lyman RS, Loucks HH. Thrombosis of the left internal carotid artery. Arch Surg. 1938; 07. 37(1):100–111.
Article
5. Chiari H. Uber das verhalten des Teilungswinkels der carotis communis bei der endarteritis chronica deformans. Verh Dtsch Ges Pathol. 1905; 9:326–330.
6. Ciccone A, Valvassori L, Nichelatti M, Sgoifo A, Ponzio M, Sterzi R, et al. Endovascular treatment for acute ischemic stroke. N Engl J Med. 2013; 03. 368(10):904–913.
Article
7. Cooley DA, Al-Naaman YD, Carton CA. Surgical treatment of arteriosclerotic occlusion of common carotid artery. J Neurosurg. 1956; 09. 13(5):500–506.
Article
8. De Bakey ME, Crawford ES, Cooley DA, Morris GC Jr. Surgical considerations of occlusive disease of innominate, carotid, subclavian, and vertebral arteries. Ann Surg. 1959; 05. 149(5):690–710.
Article
9. DeBakey ME. Successful carotid endarterectomy for cerebrovascular insufficiency. Nineteen-year follow-up. JAMA. 1975; 09. 233(10):1083–1085.
Article
10. European Carotid Surgery Trialists' Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998; 05. 351(9113):1379–1387.
11. Fields WS, Maslenikov V, Meyer JS, Hass WK, Remington RD, Macdonald M. Joint study of extracranial arterial occlusion. V. Progress report of prognosis following surgery or nonsurgical treatment for transient cerebral ischemic attacks and cervical carotid artery lesions. JAMA. 1970; 03. 211(12):1993–2003.
Article
12. Fletcher AP, Alkjaersig N, Lewis M, Tulevski V, Davies A, Brooks JE, et al. A pilot study of urokinase therapy in cerebral infarction. Stroke. 1976; Mar-Apr. 7(2):135–142.
Article
13. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999; 12. 282(21):2003–2011.
14. Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015; 03. 372(11):1019–1030.
15. Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomized trials. Lancet. 2016; 04. 387(10029):1723–1731.
16. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008; 09. 359(13):1317–1329.
Article
17. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995; 10. 274(13):1017–1025.
Article
18. Hurwitt ES, Carton CA, Fell SC, Kessler LA, Seidenberg B, Shapiro JH. Critical evaluation and surgical correction of obstructions in the branches of the aortic arch. Ann Surg. 1960; 09. 152(3):472–484.
19. Kidwell CS, Jahan R, Gornbein J, Alger JR, Nenov V, Ajani Z, et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013; 03. 368(10):914–923.
Article
20. Meyer JS, Gilroy J, Barnhart ME, Johnson JF. Therapeutic thrombolysis in cerebral thromboembolism: randomized evaluation of intravenous streptokinase. In : Millikan CH, Siekert W, Whishant JP, editors. Cerebral Vascular Diseases. Fourth Printceton conference. New York: Grune and Stratton;1964. p. 200–213.
21. Molina CA, Chamorro A, Rovira À, de Miquel A, Serena J, Roman LS, et al. REVASCAT: a randomized trial of revascularization with SOLITAIRE FR device vs. best medical therapy in the treatment of acute stroke due to anterior circulation large vessel occlusion presenting within eight-hours of symptom onset. Int J Stroke. 2015; 06. 10(4):619–626.
Article
22. Nogueira RG, Lutsep HL, Gupta R, Jovin TG, Albers GW, Walker GA, et al. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomized trial. Lancet. 2012; 10. 380(9849):1231–1240.
23. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Barnett HJM, Taylor DW, Haynes RB, Sackett DL, Peerless SJ, et al. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991; 08. 325(7):445–453.
Article
24. Robicsek F, Roush TS, Cook JW, Reames MK. From Hippocrates to Palmaz-Schatz, the history of carotid surgery. Eur J Vasc Endovasc Surg. 2004; 04. 27(4):389–397.
Article
25. Ross RS, McKusick VA. Aortic Arch syndromes: diminished or absent pulses in arteries arising from arch of aorta. AMA Arch Intern Med. 1953; 11. 92(5):701–740.
26. Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, et al. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke. Int J Stroke. 2015; 04. 10(3):439–448.
Article
27. Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet. 2012; 10. 380(9849):1241–1249.
Article
28. Shaw DA, Venables GS, Cartlidge NE, Bates D, Dickinson PH. Carotid endarterectomy in patients with transient cerebral ischaemia. J Neurol Sci. 1984; 04. 64(1):45–53.
Article
29. Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke. 2005; 07. 36(7):1432–1438.
30. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 12. 333(24):1581–1587.
31. The Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke. 2009; 08. 40(8):2761–2768.
Full Text Links
  • JCEN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr